Fondazione Cesare Serono

L'informazione è salute

L’influenza degli stupefacenti sulla qualità del liquido seminale

Parere degli esperti |time pubblicato il
L’influenza degli stupefacenti sulla qualità del liquido seminale

Gli articoli della sezione "Il parere degli esperti" riguardano alcuni fra gli argomenti più importanti e dibattuti delle rispettive aree cliniche. Dato il livello di approfondimento raggiunto, i testi possono contenere termini e concetti molto complessi. L’utilizzo del glossario potrà essere di aiuto nella comprensione di questi articoli e altri contenuti del sito, più divulgativi, contribuiranno a chiarire gli argomenti trattati.


  1. Buffum J. Pharmacosexology update: prescription drugs and sexual function. J Psychoactive Drugs 1986;18(2):97-106.
  2. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on drug use and health: National Findings. Office of Applied Studies. NSDUH Series H-36: HHS Publication SMA 09-4434. Rockville, MD.
  3. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on drug use and health: National Findings. Department of Health and Human Services. NSDUH Series H-38A;HHS Publication SMA 10-4586. Rockville, MD.
  4. Jorgensen N, Andersen AG, Eustache F, et al. Regional differences in semen quality in Europe. Hum Reprod 2001;16:1012-9.
  5. Carlsen E, Giwerman AJ, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ 1992;305:609-13.
  6. Auger J, Kutmann JM, Czyglik F, Jouanett P. Decline in semen quality of fertile men during the last 20 years. New Engl J Med 1995;332:281-5.
  7. Thompson ST. Prevention of male infertility: an update. Phenothiazines 1994;21(3):365-76.
  8. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-9.
  9. Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 1992;42:838-45.
  10. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006;58:389-462.
  11. Schuel H, Burkman LJ, Lippes J, et al. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol Reprod Dev 2002;63:376-87.
  12. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202.
  13. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-5.
  14. Rossato M, Ion Popa F, Ferigo M, Clari G, Foresta C. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab 2005;90:984-91.
  15. Vescovi PP, Pedrazzoni M, Michelini M, et al. Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol Depend 1992;30:59-63.
  16. Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol Biochem Behav 1986;24:1749-54.
  17. Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 1974;209:872-4.
  18. Whan LB, West MC, McClure N, Lewis SE. Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril 2006;85:653-60.
  19. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-22.
  20. Vuong C, Van Uum SH, O’Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010;31:98-132.
  21. Gonzalo IT, Swerdloff RS, Nelson AL, et al. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab 2002;87:3562-72.
  22. Nieschlag E. Clinical trials in male hormonal contraception. Contraception 2010;82:457-70
  23. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975-2008: Volume II, College students and adults ages 19-50. NIH Publication No.09-7403. Bethesda, MD: National Institute on Drug Abuse, 2009.
  24. Bracken MB, Eskenazi B, Sachse K, et al. Association of cocaine use with sperm concentration, motility, and morphology. Fertil Steril 1990;53:315-22.
  25. Rodriguez MC, Sanchez-Yague J, Paniagua R. Effects of cocaine on testicular structure in the rat. Reprod Toxicol 1992;6:51-5.
  26. Li H, Jiang Y, Rajpurkar A, Dunbar JC, Dhabuwala CB. Cocaine induced apoptosis in rat testes. J Urol 1999;162:213-6.
  27. Li H, George VK, Crawford SC, Dhabuwala CB. Effect of cocaine on testicular blood flow in rats: evaluation by percutaneous injection of xenon-133. J Environ Pathol Toxicol Oncol 1999;18:73-7.
  28. Vitale ML, Parisi MN, Chiocchio SR, Tramezzani JH. Serotonin induces gonadotrophin release through stimulation of LH-releasing hormone release from the median eminence. J Endocrinol 1986;111:309-15.
  29. Tsai SC, Chiao YC, Lu CC, et al. Inhibition by amphetamine of testosterone secretion through a mechanism involving an increase of cyclic AMP production in rat testes. Br J Pharmacol 1996;118:984-88.
  30. Marx J. Two major signal pathways linked. Science 1993;262:988-90.
  31. Dickerson SM, Walker DM, Reveron ME, Duvauchelle CL, Gore AC. The recreational drug ecstasy disrupts the hypothalamic-pituitary-gonadal reproductive axis in adult male rats. Neuroendocrinology 2008;88:95-102.
  32. Barenys M, Macia N, Camps L, et al. Chronic exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats. Toxicol Lett 2009;191:40-6.
  33. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335:1-7.
  34. Pope HG Jr, Brower KJ. Anabolic-androgenic steroid related disorders. In: Sadock. B, Sadock V eds. Comprehensive Textbook of Psychiatry, 9th Ed. Philadelphia, Lippincott Williams and Wilkins, 2009:1419-31.
  35. Sheffield-Moore M, Urban RJ. An overview of the endocrinology of skeletal muscle. Trends Endocrinol Metab 2004;15:110-5.
  36. Saudan C, Baume N, Robinson N, et al. Testosterone and doping control. Br J Sports Med 2006;40 Suppl 1:i21-4.
  37. Johnson MD, Jay MS, Shoup B, Rickert VI. Anabolic steroid use by male adolescents. Pediatrics 1989;8(6)921-24.
  38. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 2009;104:1966-78.
  39. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG, Jr. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry 2009;166:642-5.
  40. Tennant F, Black DL, Voy RO. Anabolic steroid dependence with opioid-type features. N Engl J Med 1988;319:578.
  41. Fudala PJ, Weinrieb RM, Calarco JS, Kampman KM, Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann Clin Psychiatry 2003;15(2)121-30.
  42. Parkinson AB, Evans N. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 2006;38:644-51.
  43. Parrott AC, Choi PY, Davies M. Anabolic steroid use by amateur athletes: effects upon psychological mood states. J Sports Med Phys Fitness 1994;34:292-8.
  44. Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994;51:375-82.
  45. Wilson-Fearon C, Parrott AC. Multiple drug use and dietary restraint in a Mr. Universe competitor: psychobiological effects. Percept Mot Skills 1999;88:578-80.
  46. Reyes-Fuentes A, Veldhuis JD. Neuroendocrine physiology of the normal male gonadal axis. Endocrinol Metab Clin North Am 1993;22:93-124.
  47. Bonetti A, Tirelli F, Catapano A, et al. Side effects of anabolic androgenic steroids abuse. Int J Sports Med 2008;29:679-87.
  48. Schurmeyer T, Knuth UA, Belkien L, Nieschlag E. Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet 1984;1:417-20.
  49. Torres-Calleja J, Gonzalez-Unzaga M, DeCelis-Carrillo R, Calzada-Sanchez L, Pedron N. Effect of androgenic anabolic steroids on sperm quality and serum hormone levels in adult male bodybuilders. Life Sci 2001;68:1769-74.
  50. Menon DK. Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. Fertil Steril 2003;79 Suppl 3:1659-61.
  51. Turek PJ, Williams RH, Gilbaugh JH, 3rd, Lipshultz LI. The reversibility of anabolic steroid-induced azoospermia. J Urol 1995;153:1628-30.


Potrebbe interessarti anche…

  1. 1
  2. 2
  3. 3